Usana Health Sciences (USNA) Net Margin (2010 - 2026)

Usana Health Sciences (USNA) has 17 years of Net Margin data on file, last reported at 2.78% in Q2 2026.

• On a quarterly basis, Net Margin fell 94.0% year-over-year to 2.78% in Q2 2026; TTM through Apr 2026 was 0.99%, a 299.0% decrease from a year earlier, with the FY2026 full-year figure at 1.24%, down 368.0% from the prior year.
• Net Margin for Q2 2026 stood at 2.78%, up from 0.71% in the prior quarter.
• Over the last five years, Net Margin for USNA reached as high as 8.23% in Q2 2022 and fell as low as 3.12% in Q3 2025.
• Historically, Net Margin has averaged 4.85% across 5 years, with a median of 5.46% in 2023.
• Across the five-year window, Net Margin soared 197 bps in 2023 and slumped 842 bps in 2025, its largest moves.
• Year by year, Net Margin stood at 5.61% in 2022, then jumped by 35 bps to 7.58% in 2023, then sank by 72 bps to 2.1% in 2024, then plunged by 249 bps to 3.12% in 2025, then soared by 189 bps to 2.78% in 2026.
• Per Business Quant data, the three most recent Net Margin figures were 2.78% in Q2 2026, 0.71% in Q1 2026, and 3.12% in Q3 2025.